HLMA Halma plc
Halma plc, together with its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. The company operates in three segments: Safety, Environmental & Analysis, and Healthcare. Its Safety segment provides products that protect people, assets, and infrastructure used in public and commercial spaces and in industrial and logistics operations. This segment serves fire safety, public safety, worker safety, and infrastructure and asset safety markets. The Environmental & Analysis segment offers technologies that monitor the environment used in optical solutions, water analysis and treatment system, and environmental monitoring technologies. Its Healthcare segment provides technologies and digital solutions for healthcare enablement, discovery, prevention, and diagnostics, and therapeutic solutions. The company also designs and manufactures differentiated orthobiologic products. Halma plc was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.…
Industry Peers
ConglomeratesKey Statistics
About Halma (LON: HLMA)
›
Halma (LON: HLMA) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Conglomerates industry, part of the Industrials sector, and reports about 9,000 employees.
The shares were at 3494.00 GBp on 19 November 2026, up 0.8% over 52 weeks. Its 52-week range is 3198.00 GBp to 4902.00 GBp: the price is 28.7% below the high and 9.3% above the low.
At a market capitalisation of 13.20B GBP, it trades at 35.7 times trailing earnings and 23.5 times forward earnings. The median trailing P/E of its 15 largest Conglomerates peers is 16.5, a premium of 116% for HLMA. It pays a dividend yielding 0.73% (it pays out 24% of its earnings), against a median of 1.26% among the dividend payers in that peer group.
Halma reports return on equity of 17.2%, an operating margin of 20.5% and revenue up 14.6% year over year.
Its debt exceeds its cash by 770.00M GBP, a debt-to-equity ratio of 0.42. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 18 analysts cover the stock, with an average rating of Buy; their mean price target of 4371.11 GBp is 25.1% above the current price. The next earnings report is expected on 19 November 2026.